New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
07:07 EDTCHTPChelsea Therapeutics volatility expected to move, FDA advisory panel recommends
Chelsea Therapeutics option implied volatility is expected to move after an FDA advisory panel voted 16-to-1 in favor of approval for the company's Northera treatment. Overall option implied volatility of 148 is near its 26-week average of 150 according to Track Data, suggesting non-directional price movement.
News For CHTP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CHTP

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use